Discontinuation of hormone replacement therapy
Journal of Prescribing Practice · 02.03.2026 · 8 (3) · 126-128
DOI: 10.12968/jprp.2026.0022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Prescribing Practice, erschienen am 02.03.2026. Verfasst von Hasan H Alsararatee. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Hormone replacement therapy (HRT) prescribing in England has increased significantly in recent years, with attention largely directed towards initiation and ongoing prescribing. However, little focus has been given to the discontinuation of therapy. This article explores the implications of HRT discontinuation in relation to safety and prescribing practice, including high rates of symptom recurrence and re-initiation of treatment, as well as the potential for increased risks of age-related cardiovascular disease and dementia.
Zitieren
APA
Alsararatee, H. H. (2026). Discontinuation of hormone replacement therapy. Journal of Prescribing Practice, 8(3), 126-128. https://doi.org/10.12968/jprp.2026.0022
Vancouver
Alsararatee HH. Discontinuation of hormone replacement therapy. Journal of Prescribing Practice. 2026;8(3):126-128. doi:10.12968/jprp.2026.0022
BibTeX
@article{Alsararatee2026,
author = {Alsararatee, Hasan H},
title = {Discontinuation of hormone replacement therapy},
journal = {Journal of Prescribing Practice},
year = {2026},
volume = {8},
number = {3},
pages = {126--128},
doi = {10.12968/jprp.2026.0022}
}
EUVIMED